430
Participants
Start Date
October 31, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
TIVc
Madin Darby Canine Kidney (MDCK) cell culture derived subunit influenza vaccine TIVc contained the purified viral envelope glycoproteins, hemagglutinin (HA) and neuraminidase (NA) derived from 3 strains (including HA for each strain \[A/H1N1-like, A/H3N2-like, and B-like\]) intramuscular (IM) injection recommended by the WHO for the 2013-2014 influenza season in the Northern Hemisphere
TIV
A conventional egg derived subunit influenza vaccine (TIV) contained the purified viral envelope-glycoproteins, HA and NA derived from 3 strains (including HA for each strain \[A/ H1N1-like, A/H3N2-like, and B-like\]) IM injection recommended by the WHO for the 2013-2014 influenza season in the Northern Hemisphere.
Novartis Investigational Site 023, Roma
Novartis Investigational Site 031, Badalona
Novartis Investigational Site 016, Castellon
Novartis Investigational Site 017, Burriana
Novartis Investigational Site 020, Genova
Novartis Investigational Site 021, Milan
Novartis Investigational Site 030, Madrid
Novartis Investigational Site 011, Málaga
Novartis Investigational Site 010, Marbella
Novartis Investigational Site 019, Valencia
Novartis Investigational Site 014, Valencia
Novartis Investigational Site 012, Valencia
Novartis Investigational Site 015, L'Eliana
Novartis Investigational Site 013, Paiporta
Novartis Investigational Site 018, Quart de Poblet
Novartis Investigational Site 022, Florence
Lead Sponsor
Novartis Vaccines
INDUSTRY